Antithymocyte Globulin for Treatment of the Bone Marrow Failure Associated with Myelodysplastic Syndromes

Figure 1. Five-year probability of survival was 76% (95% CI, 64% to 88%). Dotted lines represent the upper and lower boundaries of confidence intervals. Covariate-adjusted survival for responders and nonresponders. Response status was ascertained at 8 months after treatment with antithymocyte globulin.
Figure 1. Five-year probability of survival was 76% (95% CI, 64% to 88%). Dotted lines represent the upper and lower boundaries of confidence intervals. Covariate-adjusted survival for responders and nonresponders. Response status was ascertained at 8 months after treatment with antithymocyte globulin. Overall survival of the 61 patients enrolled in the study.Top.Bottom.

This Article

  1. Ann Intern Med August 6, 2002 vol. 137 no. 3 156-163
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues